" /> Lipodystrophy, congenital generalized, type 1 - CISMeF





Preferred Label : Lipodystrophy, congenital generalized, type 1;

Symbol : CGL1;

CISMeF acronym : BSCL1; CGL1;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Lipodystrophy, berardinelli-seip congenital, type 1; BSCL1; Brunzell syndrome, agpat2-related; Berardinelli-seip congenital lipodystrophy, type 1;

Description : Congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, is a rare autosomal recessive disease characterized by a near absence of adipose tissue from birth or early infancy and severe insulin resistance. Other clinical and biologic features include acanthosis nigricans, muscular hypertrophy, hepatomegaly, altered glucose tolerance or diabetes mellitus, and hypertriglyceridemia (Garg, 2004). - Genetic Heterogeneity of Congenital Generalized Lipodystrophy Congenital generalized lipodystrophy type 2 (269700) is caused by mutation in the BSCL2 gene (606158). Congenital generalized lipodystrophy type 3 (612526) is caused by mutation in the CAV1 gene (601047). Congenital generalized lipodystrophy type 4 (613327) is caused by mutation in the PTRF gene (603198).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutations in the 1-acylglycerol-3-phosphate O-acyltransferase 2 gene (AGPAT2, 603100.0001);

Laboratory abnormalities : Hyperinsulinemia; Hypertriglyceridemia; Decreased serum leptin; Elevated liver enzymes;

Prefixed ID : #608594;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.